GlassScriptPhysician profile
Charles E Stewart
NPI 1235380841
$6,431.62
in general payments reported to CMS, 2019-2025
25 companies · $3,322 in 2025
The $3,322 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750 · 2020: $148 · 2021: $708 · 2022: $156 · 2023: $812 · 2024: $535 · 2025: $3,322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,954 · Food and Beverage: $1,214 · Education: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,954.00 |
| Food and Beverage | $1,214.11 |
| Education | $500.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,082.64 | 2019-2025 | Mako, Actishield, Motionsense Digital Goniometer |
| Mvp Orthopedics INC | $224.38 | 2021-2022 | |
| Pacira Therapeutics, INC. | $186.94 | 2019-2021 | |
| Microport Orthopedics INC | $128.74 | 2021-2022 | |
| Orthofix Medical, INC. | $115.36 | 2021-2024 | Stim On Track, Spinal-Stim |
| Pacira Pharmaceuticals Incorporated | $75.48 | 2022-2025 | Iovera, Zilretta, Exparel |
| Depuy Synthes Sales INC. | $71.03 | 2019-2022 | |
| Medtronic USA, INC. | $64.62 | 2019-2020 | |
| Trice Medical, INC. | $55.50 | 2019 | |
| Biocomposites INC | $53.40 | 2025 | Stimulan |
| Dynasplint Systems INC. | $52.00 | 2023 | Dynasplint |
| Smith+Nephew, INC. | $45.67 | 2021-2023 | |
| Organogenesis INC. | $45.32 | 2019-2020 | |
| Bioventus LLC | $38.17 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $23.56 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coastal Medical Technologies LLC | $21.33 | 2025 | |
| Checkpoint Surgical, INC | $19.69 | 2022 | |
| Merck Sharp & Dohme LLC | $18.86 | 2025 | Zerbaxa |
| Sanofi-Aventis U.S. LLC | $17.44 | 2019 | |
| Electronic Waveform Lab, INC. | $16.70 | 2019 | |
| Ethicon US, LLC | $16.68 | 2022 | |
| Boston Scientific Corporation | $16.63 | 2019 | |
| Ferring Pharmaceuticals INC. | $16.51 | 2023 | Euflexxa |
| Avanos Medical | $16.15 | 2023 | Trivisc Sodium Hyaluronate |
| Heraeus Medical, LLC. | $8.82 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.